减重手术治疗肥胖合并多囊卵巢综合征女性的疗效
这项前瞻性非随机试验纳入90例肥胖合并多囊卵巢综合征(PCOS)女性,81例完成研究,比较药物(二甲双胍联合口服避孕药6个月后单用二甲双胍6个月)与腹腔镜袖状胃切除术的疗效,随访12个月。主要结局为PCOS完全缓解,药物组完全缓解率15%,手术组78%;终点中位BMI药物组30.1 kg/m2,手术组23.7 kg/m2。作者结论认为PCOS完全缓解取决于减重后最终BMI,因此应优先考虑减重手术。
要点
- 药物组完全缓解率15%,手术组78%,手术组明显更高。
- 终点中位BMI药物组30.1 kg/m2,手术组23.7 kg/m2。
- 最终BMI是PCOS缓解的主要影响因素,药物组切点27.5 kg/m2,手术组26 kg/m2。
核心结论
- 肥胖PCOS患者的完全缓解取决于减重后的最终BMI,因此应优先考虑减重手术。
研究设计与样本
- 前瞻性非随机试验纳入90例18至40岁、BMI≥27.5 kg/m2、腰围≥85 cm且符合2011年中国PCOS诊断标准的女性,81例完成研究。
- 药物组前6个月接受二甲双胍联合含炔雌醇和醋酸环丙孕酮的口服避孕药,后6个月单用二甲双胍;手术组接受腹腔镜袖状胃切除术;随访12个月。
- 主要结局为PCOS完全缓解,要求连续6个月经周期规律或自然妊娠。
主要发现
- 终点中位BMI药物组30.1 kg/m2,手术组23.7 kg/m2。
- PCOS完全缓解率药物组15%,手术组78%。
- 除终点BMI外,缓解与未缓解患者在游离雄激素指数、卵巢形态、胰岛素抵抗稳态模型评估和总体重减轻方面无差异。
- Logistic回归分析显示最终BMI是影响PCOS缓解的主要因素。
- 最终BMI切点药物组为27.5 kg/m2,手术组为26 kg/m2;终点BMI低于切点的患者中近95%达到完全缓解。
关键数值与推荐
- PCOS完全缓解定义为连续6个月经周期规律或自然妊娠。
- 最终BMI切点:药物组27.5 kg/m2,手术组26 kg/m2。
- 终点BMI低于切点的患者中近95%达到完全缓解。
临床怎么用
- 作者认为肥胖PCOS患者的完全缓解取决于减重后最终BMI,因此应优先考虑减重手术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The comparative effectiveness of drugs and surgical therapy for women with obesity and polycystic ovary syndrome (PCOS) has not been systematically compared. OBJECTIVE: We aimed to determine the difference in efficacy between drug and bariatric surgery therapy for women with obesity and PCOS. METHODS: This prospective nonrandomized trial enrolled 90 women aged 18 to 40 years with body mass index (BMI) ≥ 27.5 kg/m2 and waist circumference ≥ 85 cm and fulfilling the 2011 Chinese diagnostic criteria for PCOS; 81 subjects completed the study. In the drug group, patients were administered metformin and an oral contraceptive containing ethinyl-estradiol and cyproterone acetate for the first 6 months, and metformin alone for the second 6 months. In the surgical group, patients underwent laparoscopic sleeve gastrectomies. The follow-up period was 12 months. The main outcome was the complete remission of PCOS, requiring 6 consecutive regular menstruation cycles or spontaneous pregnancy. RESULTS: Median BMI at endpoint was 30.1 kg/m2 in the drug group and 23.7 kg/m2 in the surgical group; complete remission rate was 15% and 78%, respectively. Except endpoint BMI, no difference was observed in free androgen index, ovarian morphology, homeostasis model assessment for insulin resistance, and total weight loss between remission and nonremission patients. Logistic regression analyses also revealed that the final BMI was the major factor influencing the remission of PCOS. The cutoff points for the final BMI were 27.5 kg/m2 for the drug group and 26 kg/m2 for the surgical group. Overall, nearly 95% of patients with an endpoint BMI below the cutoff values achieved complete remission. CONCLUSION: Complete remission of PCOS in patients with obesity depends on the final BMI after weight loss. Thus, bariatric surgery should be prioritized for these patients.
引用
- Hu L, Ma L, Xia X, et al. Efficacy of Bariatric Surgery in the Treatment of Women With Obesity and Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2022. PMID: 35554540. doi:10.1210/clinem/dgac294
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。